• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低密度脂蛋白分离术与家族性高胆固醇血症冠状动脉粥样硬化的改善——计算机化定量冠状动脉造影与尸检结果的相关性

LDL-apheresis and improvement in the coronary atherosclerosis of familial hypercholesterolemia--correlation of computerized quantitative coronary angiography with autopsy findings.

作者信息

Koga N, Satoh T, Watanabe K, Kohchi K, Iwata Y, Minami H

机构信息

Department of Cardiology, Koga Hospital, Kurume City, Japan.

出版信息

Biomater Artif Cells Immobilization Biotechnol. 1991;19(1):37-52. doi: 10.3109/10731199109117814.

DOI:10.3109/10731199109117814
PMID:1751679
Abstract

We have evaluated the effects of LDL-aphereses performed over 15 to 62 months, involving both Double Filtration Plasmapheresis (DFPP) and LDL Adsorbent Plasmapheresis (LAPP), for 5 patients with familial hypercholesterolemia (FH) (1; homozygous, and 4; heterozygous) using computer image analysis by coronary angiography, (CAG). Results by CAG showed that in homozygous FH, 9 (75%) of 12 segments demonstrated no progression, 2 (16.7%) segments showed regression, and only 1 (8.3%) segment showed progression. In heterozygous FH, 27 (81.8%) of 33 segments showed progression, and 6 (18.2%) segments showed regression. Aorto coronary bypass was beneficial with obtained patency in 13 (93%) of the 14 grafts. We also performed an autopsy on one patient, with heterozygous FH who died suddenly probably due to fibrillation. The patient had received long-term LDL apheresis for 6 years and 7 months and had shown angiographic regression. The pathological findings showed no typical or new atheroma, significant cicatrization in the thickened intima and an eccentric thickened wall lesion. The serial angiographic findings together with the pathological findings very clearly support the use of LDL-apheresis for producing "true" regression in coronary atherosclerosis in FH.

摘要

我们对5例家族性高胆固醇血症(FH)患者(1例纯合子,4例杂合子)进行了15至62个月的低密度脂蛋白分离治疗效果评估,治疗方法包括双重滤过血浆置换(DFPP)和低密度脂蛋白吸附血浆置换(LAPP),采用冠状动脉造影(CAG)计算机图像分析技术。CAG结果显示,在纯合子FH患者中,12个节段中有9个(75%)无进展,2个节段(16.7%)出现消退,仅1个节段(8.3%)有进展。在杂合子FH患者中,33个节段中有27个(81.8%)有进展,6个节段(18.2%)出现消退。14例移植血管中有13例(93%)的主动脉冠状动脉旁路移植术通畅。我们还对1例杂合子FH患者进行了尸检,该患者可能因房颤突然死亡。该患者接受了6年7个月的长期低密度脂蛋白分离治疗,血管造影显示有消退。病理检查结果显示无典型或新的动脉粥样硬化,增厚的内膜有明显瘢痕形成,且有偏心性增厚的壁病变。连续的血管造影结果和病理检查结果非常明确地支持在FH患者的冠状动脉粥样硬化中使用低密度脂蛋白分离治疗以产生“真正的”消退。

相似文献

1
LDL-apheresis and improvement in the coronary atherosclerosis of familial hypercholesterolemia--correlation of computerized quantitative coronary angiography with autopsy findings.低密度脂蛋白分离术与家族性高胆固醇血症冠状动脉粥样硬化的改善——计算机化定量冠状动脉造影与尸检结果的相关性
Biomater Artif Cells Immobilization Biotechnol. 1991;19(1):37-52. doi: 10.3109/10731199109117814.
2
Pathological and angiographic regression of coronary atherosclerosis by LDL-apheresis in a patient with familial hypercholesterolemia.
Atherosclerosis. 1991 Sep;90(1):9-21. doi: 10.1016/0021-9150(91)90239-y.
3
Angiographic and pathological studies on regression of coronary atherosclerosis of FH patients who received LDL-apheresis treatment.对接受低密度脂蛋白单采治疗的家族性高胆固醇血症(FH)患者冠状动脉粥样硬化消退的血管造影和病理学研究。
Artif Organs. 1992 Apr;16(2):171-6. doi: 10.1111/j.1525-1594.1992.tb00289.x.
4
The retardation of progression, stabilization, and regression of coronary and carotid atherosclerosis by low-density lipoprotein apheresis in patients with familial hypercholesterolemia.
Ther Apher. 1997 Aug;1(3):260-70. doi: 10.1111/j.1744-9987.1997.tb00149.x.
5
Coronary atherosclerosis reduced in patients with familial hypercholesterolemia after intensive cholesterol lowering with low-density lipoprotein-apheresis: 1-year follow-up study. The Osaka LDL-Apheresis Multicenter Trial Group.家族性高胆固醇血症患者经低密度脂蛋白单采术强化降低胆固醇后冠状动脉粥样硬化减轻:1年随访研究。大阪低密度脂蛋白单采术多中心试验组。
Clin Ther. 1994 May-Jun;16(3):416-28.
6
[A case of heterozygous familial hypercholesterolemia showing the regression of coronary atherosclerosis by LDL-apheresis].[1例杂合子家族性高胆固醇血症经低密度脂蛋白单采术使冠状动脉粥样硬化消退的病例]
Kokyu To Junkan. 1992 Mar;40(3):299-302.
7
Long-term efficacy of low-density lipoprotein apheresis on coronary heart disease in familial hypercholesterolemia. Hokuriku-FH-LDL-Apheresis Study Group.低密度脂蛋白分离术对家族性高胆固醇血症冠心病的长期疗效。北陆家族性高胆固醇血症-低密度脂蛋白分离术研究组。
Am J Cardiol. 1998 Dec 15;82(12):1489-95. doi: 10.1016/s0002-9149(98)00692-4.
8
Regression of coronary atherosclerosis by combined LDL-apheresis and lipid-lowering drug therapy in patients with familial hypercholesterolemia: a multicenter study. The LARS Investigators.家族性高胆固醇血症患者联合低密度脂蛋白去除术与降脂药物治疗对冠状动脉粥样硬化的消退作用:一项多中心研究。LARS研究组。
Atherosclerosis. 1992 Jul;95(1):1-13. doi: 10.1016/0021-9150(92)90170-l.
9
Apheresis technology for prevention and regression of atherosclerosis.
Ther Apher. 2001 Aug;5(4):221-5. doi: 10.1046/j.1526-0968.2001.00328.x.
10
[Regression of coronary sclerosis in familial hypercholesterolemia IIa by specific LDL apheresis].[家族性高胆固醇血症IIa型中通过特异性低密度脂蛋白去除术实现冠状动脉硬化的消退]
Dtsch Med Wochenschr. 1986 Nov 7;111(45):1709-15. doi: 10.1055/s-2008-1068697.

引用本文的文献

1
Lipoprotein apheresis: an established therapeutic modality for homozygous familial hypercholesterolemia patients refractory to PCSK9 inhibitors: a case report and literature review.脂蛋白分离术:一种治疗对PCSK9抑制剂难治的纯合子家族性高胆固醇血症患者的既定治疗方式:病例报告及文献综述
Thromb J. 2024 Oct 3;22(1):85. doi: 10.1186/s12959-024-00657-w.